BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 1983489)

  • 41. Management for patients with advanced T4 epidermoid carcinoma of the esophagus.
    Wang LS; Chi KH; Hu MH; Fahn HJ; Huang MH
    J Surg Oncol; 1996 May; 62(1):22-9. PubMed ID: 8618396
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
    Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Squamous cell cancer of the esophagus. Treatment concept at the National Cancer Center in Tokyo].
    Watanabe H
    Chirurg; 1992 Sep; 63(9):689-92. PubMed ID: 1395873
    [No Abstract]   [Full Text] [Related]  

  • 44. Palliative chemotherapy does not improve survival in metastatic esophageal cancer.
    Adenis A; Penel N; Horn S; Dominguez S; Vanhuyse M; Mirabel X
    Oncology; 2010; 79(1-2):46-54. PubMed ID: 21071989
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Neoadjuvant therapy for squamous cell carcinoma of the esophagus].
    Lordick F
    Chirurg; 2005 Nov; 76(11):1025-32. PubMed ID: 16220341
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The immunological impact of neoadjuvant chemotherapy on the tumor microenvironment of esophageal squamous cell carcinoma.
    Tsuchikawa T; Miyamoto M; Yamamura Y; Shichinohe T; Hirano S; Kondo S
    Ann Surg Oncol; 2012 May; 19(5):1713-9. PubMed ID: 21822560
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic role of cyclooxygenase-2 in neoadjuvant-treated patients with squamous cell carcinoma of the esophagus.
    Sivula A; Buskens CJ; van Rees BP; Haglund C; Offerhaus GJ; van Lanschot JJ; Ristimäki A
    Int J Cancer; 2005 Oct; 116(6):903-8. PubMed ID: 15856454
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Retrospective Study of Adjuvant Chemotherapy Effects on Survival Rate after Three-Field Lymph Node Dissection for Stage IIA Esophageal Cancer.
    Chen HX; Wang Z
    Asian Pac J Cancer Prev; 2015; 16(13):5169-73. PubMed ID: 26225648
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Multimodality therapy concepts in esophageal carcinoma].
    Siewert JR; Ott K
    Kongressbd Dtsch Ges Chir Kongr; 2001; 118():39-43. PubMed ID: 11824282
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Small cell carcinoma of the esophagus: a report of 16 cases from a single institution and literature review.
    Kuo CH; Hsieh CC; Chan ML; Li AF; Huang MH; Hsu WH; Hsu HS
    Ann Thorac Surg; 2011 Feb; 91(2):373-8. PubMed ID: 21256272
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Preoperative (neoadjuvant) chemotherapy in squamous cell cancer of the esophagus.
    Schlag P; Herrmann R; Raeth U; Lehner B; Schwarz V; Herfarth C
    Recent Results Cancer Res; 1988; 110():14-20. PubMed ID: 2457237
    [No Abstract]   [Full Text] [Related]  

  • 52. [No improvement of prognosis by neoadjuvant chemotherapy alone in operable esophageal carcinoma].
    Fietkau R
    Strahlenther Onkol; 1999 May; 175(5):251-2. PubMed ID: 10356618
    [No Abstract]   [Full Text] [Related]  

  • 53. [Clinical experience of topical treatments for liver metastases from esophageal carcinoma].
    Wada N; Yamasaki M; Hayashi T; Miyata H; Takahashi T; Kurokawa Y; Nakajima K; Takiguchi S; Mori M; Doki Y
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):2158-60. PubMed ID: 24394045
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Editorial on combined therapy for squamous cell carcinoma of the esophagus.
    Skinner DB
    J Thorac Cardiovasc Surg; 1997 Aug; 114(2):203-4. PubMed ID: 9270636
    [No Abstract]   [Full Text] [Related]  

  • 55. [Prognostic evaluation of squamous cell carcinoma of the esophagus].
    Kolosov AE; Dovgaliuk AZ; Stoliarov VI
    Sov Med; 1991; (10):68-9. PubMed ID: 1801242
    [No Abstract]   [Full Text] [Related]  

  • 56. [Combined therapy of inoperable esophageal cancer].
    Fink U; Pfeiffer G; Gossmann A; Lukas P; Wilke HJ; Preusser P; Siewert JR
    Z Gastroenterol Verh; 1991 Mar; 26():209-16. PubMed ID: 1714151
    [No Abstract]   [Full Text] [Related]  

  • 57. [Esophageal carcinoma: non-surgical therapy].
    Geissler M; Schwacha H; Eggstein S; Usadel H; Harder J; Opitz O; Arnold C; Grimm CF; Blum HE
    Praxis (Bern 1994); 2004 Dec; 93(49):2057-64. PubMed ID: 15630988
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The effect of preoperative radiation therapy on the results of the combined treatment of esophageal cancer].
    Mamontov AS; Kukharenko VM; Zimina ES; Dostanova TK
    Med Radiol (Mosk); 1991; 36(11):26-30. PubMed ID: 1943565
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Current standards and options in the treatment of squamous cell oesophageal carcinoma.
    Mariette C
    Eur J Cancer; 2009 Sep; 45 Suppl 1():452-4. PubMed ID: 19775668
    [No Abstract]   [Full Text] [Related]  

  • 60. [Chemotherapy and surgery compared to surgery alone in localized cancer of the esophagus].
    Huguier M
    Chirurgie; 1999 Sep; 124(4):455-6. PubMed ID: 10546402
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.